Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Cyclerion Therapeutics, Inc. (CYCN) had Operating Cash Flow per Share of $-1.04 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$1.02M |
|
$-0.80M |
|
-- |
|
$1.02M |
|
$1.86M |
|
$-0.84M |
|
$0.04M |
|
$-0.80M |
|
$-0.80M |
|
$-0.80M |
|
$-0.80M |
|
$-0.80M |
|
$-0.80M |
|
$-0.84M |
|
$-0.84M |
|
3.18M |
|
3.18M |
|
$-0.14 |
|
$-0.14 |
|
| Balance Sheet Financials | |
$4.63M |
|
-- |
|
$5.35M |
|
$9.98M |
|
$0.90M |
|
-- |
|
-- |
|
$0.90M |
|
$9.09M |
|
$9.09M |
|
$9.09M |
|
3.82M |
|
| Cash Flow Statement Financials | |
$-3.31M |
|
-- |
|
$3.32M |
|
$3.23M |
|
$3.24M |
|
$0.01M |
|
$0.44M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.15 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-81.76% |
|
-81.76% |
|
-- |
|
-77.95% |
|
-77.95% |
|
$-3.31M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
-- |
|
1.02 |
|
87.80 |
|
-8.79% |
|
-8.79% |
|
-8.00% |
|
-8.79% |
|
$2.38 |
|
$-1.04 |
|
|
Operating Cash Flow per Share |
$-1.04 |